Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study.

ABSTRACT:

Background

Cervical cancer is the fourth most common cancer in women worldwide, and women with human immunodeficiency virus (HIV) are particularly at risk of developing it. Regular screening effectively prevents morbidity and mortality. This mixed-methods study quantitatively assessed cervical cancer screening uptake and qualitatively explored the process of undergoing cervical cancer screening to understand possible reasons for delayed screening among women with HIV in Lesotho.

Methods

Between October 2020 and March 2022, the Viral load Triggered ART care in Lesotho (VITAL) trial enrolled women aged 18 years and older with HIV who were taking antiretroviral therapy (ART). Cervical cancer screening delay was defined as reporting a screening that occurred more than two years

SUBMITTER: Harder MT 

PROVIDER: S-EPMC11446098 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature